LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated Chemotaxis.

    Don-Doncow, Nicholas / Vanherle, Lotte / Zhang, Yun / Meissner, Anja

    International journal of molecular sciences

    2019  Volume 20, Issue 3

    Abstract: Hypertension is considered the major modifiable risk factor for the development of cognitive impairment. Because increased blood pressure is often accompanied by an activation of the immune system, the concept of neuro-inflammation gained increasing ... ...

    Abstract Hypertension is considered the major modifiable risk factor for the development of cognitive impairment. Because increased blood pressure is often accompanied by an activation of the immune system, the concept of neuro-inflammation gained increasing attention in the field of hypertension-associated neurodegeneration. Particularly, hypertension-associated elevated circulating T-lymphocyte populations and target organ damage spurred the interest to understanding mechanisms leading to inflammation-associated brain damage during hypertension. The present study describes sphingosine-1-phosphate (S1P) as major contributor to T-cell chemotaxis to the brain during hypertension-associated neuro-inflammation and cognitive impairment. Using Western blotting, flow cytometry and mass spectrometry approaches, we show that hypertension stimulates a sphingosine kinase 1 (SphK1)-dependent increase of cerebral S1P concentrations in a mouse model of angiotensin II (AngII)-induced hypertension. The development of a distinct S1P gradient between circulating blood and brain tissue associates to elevated CD3+ T-cell numbers in the brain. Inhibition of S1P₁-guided T-cell chemotaxis with the S1P receptor modulator FTY720 protects from augmentation of brain CD3 expression and the development of memory deficits in hypertensive WT mice. In conclusion, our data highlight a new approach to the understanding of hypertension-associated inflammation in degenerative processes of the brain during disease progression.
    MeSH term(s) Angiotensin II ; Animals ; Brain/immunology ; Brain/pathology ; Chemokines/genetics ; Chemokines/metabolism ; Chemotaxis ; Cognition Disorders/complications ; Cognition Disorders/immunology ; Female ; Hypertension/complications ; Hypertension/immunology ; Lysophospholipids/metabolism ; Male ; Memory Disorders/complications ; Memory Disorders/immunology ; Memory Disorders/prevention & control ; Mice, Inbred C57BL ; Mice, Transgenic ; Models, Biological ; Phosphotransferases (Alcohol Group Acceptor)/metabolism ; Sphingosine/analogs & derivatives ; Sphingosine/metabolism ; T-Lymphocytes/immunology
    Chemical Substances Chemokines ; Lysophospholipids ; Angiotensin II (11128-99-7) ; sphingosine 1-phosphate (26993-30-6) ; Phosphotransferases (Alcohol Group Acceptor) (EC 2.7.1.-) ; sphingosine kinase (EC 2.7.1.-) ; Sphingosine (NGZ37HRE42)
    Language English
    Publishing date 2019-01-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms20030537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Improving Cerebrovascular Function to Increase Neuronal Recovery in Neurodegeneration Associated to Cardiovascular Disease.

    Vanherle, Lotte / Matuskova, Hana / Don-Doncow, Nicholas / Uhl, Franziska E / Meissner, Anja

    Frontiers in cell and developmental biology

    2020  Volume 8, Page(s) 53

    Abstract: Mounting evidence indicates that the presence of cardiovascular disease (CVD) and risk factors elevates the incidence of cognitive impairment (CI) and dementia. CVD and associated decline in cardiovascular function can impair cerebral blood flow (CBF) ... ...

    Abstract Mounting evidence indicates that the presence of cardiovascular disease (CVD) and risk factors elevates the incidence of cognitive impairment (CI) and dementia. CVD and associated decline in cardiovascular function can impair cerebral blood flow (CBF) regulation, leading to the disruption of oxygen and nutrient supply in the brain where limited intracellular energy storage capacity critically depends on CBF to sustain proper neuronal functioning. During hypertension and acute as well as chronic CVD, cerebral hypoperfusion and impaired cerebrovascular function are often associated with neurodegeneration and can lead to CI and dementia. Currently, all forms of neurodegeneration associated to CVD lack effective treatments, which highlights the need to better understand specific mechanisms linking cerebrovascular dysfunction and CBF deficits to neurodegeneration. In this review, we discuss vascular targets that have already shown attenuation of neurodegeneration or CI associated to hypertension, heart failure (HF) and stroke by improving cerebrovascular function or CBF deficits.
    Language English
    Publishing date 2020-02-07
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2737824-X
    ISSN 2296-634X
    ISSN 2296-634X
    DOI 10.3389/fcell.2020.00053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension.

    Don-Doncow, Nicholas / Zhang, Yun / Matuskova, Hana / Meissner, Anja

    British journal of pharmacology

    2018  Volume 176, Issue 12, Page(s) 1989–2001

    Abstract: The immune system plays a considerable role in hypertension. In particular, T-lymphocytes are recognized as important players in its pathogenesis. Despite substantial experimental efforts, the molecular mechanisms underlying the nature of T-cell ... ...

    Abstract The immune system plays a considerable role in hypertension. In particular, T-lymphocytes are recognized as important players in its pathogenesis. Despite substantial experimental efforts, the molecular mechanisms underlying the nature of T-cell activation contributing to an onset of hypertension or disease perpetuation are still elusive. Amongst other cell types, lymphocytes express distinct profiles of GPCRs for sphingosine-1-phosphate (S1P) - a bioactive phospholipid that is involved in many critical cell processes and most importantly majorly regulates T-cell development, lymphocyte recirculation, tissue-homing patterns and chemotactic responses. Recent findings have revealed a key role for S1P chemotaxis and T-cell mobilization for the onset of experimental hypertension, and elevated circulating S1P levels have been linked to several inflammation-associated diseases including hypertension in patients. In this article, we review the recent progress towards understanding how S1P and its receptors regulate immune cell trafficking and function and its potential relevance for the pathophysiology of hypertension. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.
    MeSH term(s) Animals ; Humans ; Hypertension/immunology ; Hypertension/pathology ; Lysophospholipids/immunology ; Signal Transduction/immunology ; Sphingosine/analogs & derivatives ; Sphingosine/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology
    Chemical Substances Lysophospholipids ; sphingosine 1-phosphate (26993-30-6) ; Sphingosine (NGZ37HRE42)
    Language English
    Publishing date 2018-07-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80081-8
    ISSN 1476-5381 ; 0007-1188
    ISSN (online) 1476-5381
    ISSN 0007-1188
    DOI 10.1111/bph.14381
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia.

    Don-Doncow, Nicholas / Vanherle, Lotte / Matthes, Frank / Petersen, Sine Kragh / Matuskova, Hana / Rattik, Sara / Härtlova, Anetta / Meissner, Anja

    NPJ aging and mechanisms of disease

    2021  Volume 7, Issue 1, Page(s) 19

    Abstract: Evidence associates cardiovascular risk factors with unfavorable systemic and neuro-inflammation and cognitive decline in the elderly. Cardiovascular therapeutics (e.g., statins and anti-hypertensives) possess immune-modulatory functions in parallel to ... ...

    Abstract Evidence associates cardiovascular risk factors with unfavorable systemic and neuro-inflammation and cognitive decline in the elderly. Cardiovascular therapeutics (e.g., statins and anti-hypertensives) possess immune-modulatory functions in parallel to their cholesterol- or blood pressure (BP)-lowering properties. How their ability to modify immune responses affects cognitive function is unknown. Here, we examined the effect of chronic hypercholesterolemia on inflammation and memory function in Apolipoprotein E (ApoE) knockout mice and normocholesterolemic wild-type mice. Chronic hypercholesterolemia that was accompanied by moderate blood pressure elevations associated with apparent immune system activation characterized by increases in circulating pro-inflammatory Ly6Chi monocytes in ApoE
    Language English
    Publishing date 2021-08-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2836493-4
    ISSN 2056-3973
    ISSN 2056-3973
    DOI 10.1038/s41514-021-00071-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Expression of tSTAT3, pSTAT3

    Krzyzanowska, Agnieszka / Don-Doncow, Nicholas / Marginean, Felicia Elena / Gaber, Alexander / Watson, R William / Hellsten, Rebecka / Bjartell, Anders

    The Prostate

    2019  Volume 79, Issue 7, Page(s) 784–797

    Abstract: Background: The signal transducer and activator of transcription 3 (STAT3) pathway is observed to be constitutively activated in several malignancies including prostate cancer (PCa). In the present study, we investigated the expression of total STAT3 ( ... ...

    Abstract Background: The signal transducer and activator of transcription 3 (STAT3) pathway is observed to be constitutively activated in several malignancies including prostate cancer (PCa). In the present study, we investigated the expression of total STAT3 (tSTAT3) and two forms of activated phosphorylated STAT3 (pSTAT3
    Methods: The expression of tSTAT3, pSTAT3
    Results: The nuclear expression levels of tSTAT3, pSTAT3
    Conclusions: Low pSTAT3
    MeSH term(s) Aged ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/biosynthesis ; Biomarkers, Tumor/metabolism ; Epithelial Cells/metabolism ; Humans ; Male ; Middle Aged ; Phosphorylation ; Prostate/chemistry ; Prostate/metabolism ; Prostate/surgery ; Prostatectomy ; Prostatic Neoplasms/chemistry ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/surgery ; STAT3 Transcription Factor/analysis ; STAT3 Transcription Factor/biosynthesis ; STAT3 Transcription Factor/metabolism ; Tissue Array Analysis
    Chemical Substances Biomarkers, Tumor ; STAT3 Transcription Factor ; STAT3 protein, human
    Language English
    Publishing date 2019-03-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604707-5
    ISSN 1097-0045 ; 0270-4137
    ISSN (online) 1097-0045
    ISSN 0270-4137
    DOI 10.1002/pros.23787
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Alterations to Cerebral Perfusion, Metabolite Profiles, and Neuronal Morphology in the Hippocampus and Cortex of Male and Female Mice during Chronic Exposure to a High-Salt Diet

    Anja Meissner / Alba M. Garcia-Serrano / Lotte Vanherle / Zeinab Rafiee / Nicholas Don-Doncow / Cecilia Skoug / Sara Larsson / Michael Gottschalk / Martin Magnusson / João M. N. Duarte

    International Journal of Molecular Sciences, Vol 24, Iss 1, p

    2022  Volume 300

    Abstract: Excess dietary salt reduces resting cerebral blood flow (CBF) and vascular reactivity, which can limit the fueling of neuronal metabolism. It is hitherto unknown whether metabolic derangements induced by high-salt-diet (HSD) exposure during adulthood are ...

    Abstract Excess dietary salt reduces resting cerebral blood flow (CBF) and vascular reactivity, which can limit the fueling of neuronal metabolism. It is hitherto unknown whether metabolic derangements induced by high-salt-diet (HSD) exposure during adulthood are reversed by reducing salt intake. In this study, male and female mice were fed an HSD from 9 to 16 months of age, followed by a normal-salt diet (ND) thereafter until 23 months of age. Controls were continuously fed either ND or HSD. CBF and metabolite profiles were determined longitudinally by arterial spin labeling magnetic resonance imaging and magnetic resonance spectroscopy, respectively. HSD reduced cortical and hippocampal CBF, which recovered after dietary salt normalization, and affected hippocampal but not cortical metabolite profiles. Compared to ND, HSD increased hippocampal glutamine and phosphocreatine levels and decreased creatine and choline levels. Dietary reversal only allowed recovery of glutamine levels. Histology analyses revealed that HSD reduced the dendritic arborization and spine density of cortical and hippocampal neurons, which were not recovered after dietary salt normalization. We conclude that sustained HSD exposure throughout adulthood causes permanent structural and metabolic alterations to the mouse brain that are not fully normalized by lowering dietary salt during aging.
    Keywords neurodegeneration ; metabolism ; hypertension ; sodium ; CBF ; MRS ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 590
    Language English
    Publishing date 2022-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Expression of STAT3 in Prostate Cancer Metastases.

    Don-Doncow, Nicholas / Marginean, Felicia / Coleman, Ilsa / Nelson, Peter S / Ehrnström, Roy / Krzyzanowska, Agnieszka / Morrissey, Colm / Hellsten, Rebecka / Bjartell, Anders

    European urology

    2016  Volume 71, Issue 3, Page(s) 313–316

    Abstract: STAT3 and its upstream activator IL6R have been implicated in the progression of prostate cancer and are possible future therapeutic targets. We analyzed 223 metastatic samples from rapid autopsies of 71 patients who had died of castration-resistant ... ...

    Abstract STAT3 and its upstream activator IL6R have been implicated in the progression of prostate cancer and are possible future therapeutic targets. We analyzed 223 metastatic samples from rapid autopsies of 71 patients who had died of castration-resistant prostate cancer (CRPC) to study protein and gene expression of pSTAT3 and IL6R. Immunohistochemical analysis revealed that 95% of metastases were positive for pSTAT3 and IL6R, with varying expression levels. Bone metastases showed significantly higher expression of both pSTAT3 and IL6R in comparison to lymph node and visceral metastases. STAT3 mRNA levels were significantly higher in bone than in lymph node and visceral metastases, whereas no significant difference in IL6R mRNA expression was observed. Our study strongly supports the suggested view of targeting STAT3 as a therapeutic option in patients with metastatic CRPC.
    Patient summary: We studied the levels of two proteins (pSTAT3 and IL6R) in metastases from patients who died from castration-resistant prostate cancer. We found high levels of pSTAT3and IL6R in bone metastases, suggesting that these proteins could be used as targets for new anticancer drugs.
    MeSH term(s) Adenocarcinoma/genetics ; Adenocarcinoma/metabolism ; Adenocarcinoma/secondary ; Autopsy ; Benzamides/metabolism ; Bone Neoplasms/genetics ; Bone Neoplasms/metabolism ; Bone Neoplasms/secondary ; Humans ; Immunohistochemistry ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Liver Neoplasms/secondary ; Lymph Nodes/metabolism ; Lymphatic Metastasis ; Male ; Neoplasm Metastasis ; Phosphoproteins/metabolism ; Piperidines/metabolism ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Receptors, Interleukin-6/genetics ; Receptors, Interleukin-6/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; Transcriptome
    Chemical Substances Benzamides ; IL6R protein, human ; N-phenyl-N-(1-(piperidine-1-carbonyl)cyclohexyl)benzamide ; Phosphoproteins ; Piperidines ; Receptors, Interleukin-6 ; STAT3 Transcription Factor ; STAT3 protein, human
    Language English
    Publishing date 2016-06-22
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2016.06.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cells.

    Don-Doncow, Nicholas / Escobar, Zilma / Johansson, Martin / Kjellström, Sven / Garcia, Victor / Munoz, Eduardo / Sterner, Olov / Bjartell, Anders / Hellsten, Rebecka

    The Journal of biological chemistry

    2014  Volume 289, Issue 23, Page(s) 15969–15978

    Abstract: The transcription factor STAT3 is constitutively active in several malignancies including castration-resistant prostate cancer and has been identified as a promising therapeutic target. The fungal metabolite galiellalactone, a STAT3 signaling inhibitor, ... ...

    Abstract The transcription factor STAT3 is constitutively active in several malignancies including castration-resistant prostate cancer and has been identified as a promising therapeutic target. The fungal metabolite galiellalactone, a STAT3 signaling inhibitor, inhibits the growth, both in vitro and in vivo, of prostate cancer cells expressing active STAT3 and induces apoptosis of prostate cancer stem cell-like cells expressing phosphorylated STAT3 (pSTAT3). However, the molecular mechanism of this STAT3-inhibiting effect by galiellalactone has not been clarified. A biotinylated analogue of galiellalactone (GL-biot) was synthesized to be used for identification of galiellalactone target proteins. By adding streptavidin-Sepharose beads to GL-biot-treated DU145 cell lysates, STAT3 was isolated and identified as a target protein. Confocal microscopy revealed GL-biot in both the cytoplasm and the nucleus of DU145 cells treated with GL-biot, appearing to co-localize with STAT3 in the nucleus. Galiellalactone inhibited STAT3 binding to DNA in DU145 cell lysates without affecting phosphorylation status of STAT3. Mass spectrometry analysis of recombinant STAT3 protein pretreated with galiellalactone revealed three modified cysteines (Cys-367, Cys-468, and Cys-542). Here we demonstrate with chemical and molecular pharmacological methods that galiellalactone is a cysteine reactive inhibitor that covalently binds to one or more cysteines in STAT3 and that this leads to inhibition of STAT3 binding to DNA and thus blocks STAT3 signaling without affecting phosphorylation. This further validates galiellalactone as a promising direct STAT3 inhibitor for treatment of castration-resistant prostate cancer.
    MeSH term(s) Amino Acid Sequence ; Blotting, Western ; Cell Line, Tumor ; Cell Proliferation ; Humans ; Lactones/pharmacology ; Magnetic Resonance Spectroscopy ; Male ; Mass Spectrometry ; Models, Molecular ; Molecular Sequence Data ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Protein Binding ; STAT3 Transcription Factor/antagonists & inhibitors ; STAT3 Transcription Factor/chemistry ; STAT3 Transcription Factor/metabolism
    Chemical Substances Lactones ; STAT3 Transcription Factor ; STAT3 protein, human ; galiellalactone
    Language English
    Publishing date 2014-04-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.M114.564252
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top